Investigations
Every investigation we've published, newest first — each one built on primary documents and classified under our evidence standard.
Corporations — 3 September 2024 — 6 min read
The FTC investigated Perion Network over advertising technology practices it found misrepresented consumers' ability to opt out of tracking and continued to collect behavioral data through mechanisms that ignored or circumvented consumer privacy choices, in violation of the FTC Act's prohibition on deceptive practices.
Read the full report →
Corporations — 29 August 2024 — 7 min read
The SEC charged Smith Douglas Homes with understating its warranty reserve liability in financial statements included in its IPO registration statement — finding the accrued reserve did not adequately reflect the company's historical warranty claims and that the understatement inflated reported net income in the periods before the public offering.
Read the full report →
Fraud & Deception — 28 August 2024 — 7 min read
RivX told consumers that for $75,000, it would buy a semi-truck, hire the driver, and run the business — generating passive income within 60 days. The FTC says very few consumers ever received a truck.
Read the full report →
Corporations — 27 August 2024 — 6 min read
The SEC settlement with Transamerica Life Insurance's parent company resolved charges that material weaknesses in the company's actuarial reserve calculation controls resulted in approximately $2 billion in reserve restatements — errors that affected the financial statements investors relied on to assess the company's solvency and capital position.
Read the full report →
Corporations — 20 August 2024 — 7 min read
The SEC charged Citius Pharmaceuticals with making materially misleading statements about the statistical design and powering of its Phase 3 clinical trial for a hospital-acquired infection treatment, finding investor presentations overstated the trial's scientific rigor and the probability of meeting regulatory approval standards.
Read the full report →
Corporations — 19 August 2024 — 6 min read
The FTC investigated Carvana over a systematic pattern of failing to deliver vehicle titles and registration documents to customers within state-mandated timeframes, leaving thousands of buyers unable to legally operate or transfer vehicles they had purchased and paid for.
Read the full report →
Corporations — 16 August 2024 — 8 min read
Salespeople got consumers to agree to a monthly payment bigger than the car required, then quietly filled the gap with add-ons — a tactic the FTC calls 'payment packing,' allegedly worse for Black and Latino buyers.
Read the full report →
Corporations — 15 August 2024 — 7 min read
A century-old family dealership advertised discounted prices online, then routinely added unauthorized charges — with Latino buyers paying nearly $1,200 more on average, the FTC and Arizona allege.
Read the full report →
Corporations — 15 August 2024 — 6 min read
The SEC alleged Meditrina Inc. raised $10 million from investors using fabricated clinical trial results and validation studies for its AI-powered medical analysis software, with the founder personally directing the falsification.
Read the full report →
Corporations — 14 August 2024 — 7 min read
The SEC charged Bioventus with recognizing revenue on shipments of its orthobiologics products to distributors before applicable revenue recognition criteria were satisfied, overstating reported revenue and creating a misleading picture of commercial demand that investors used to assess the company's growth trajectory.
Read the full report →
Fraud & Deception — 8 August 2024 — 6 min read
A month before its founder settled his own charges, two other operators of the sprawling Blueprint to Wealth scheme agreed to their own permanent bans from the business-opportunity industry.
Read the full report →
Corporations — 8 August 2024 — 7 min read
The FTC found Dun and Bradstreet had failed to maintain reasonable procedures to ensure the accuracy of information in its commercial credit files — errors affecting small businesses' ability to access financing, insurance, and business opportunities based on inaccurate credit data they had no reliable mechanism to identify or correct.
Read the full report →